• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[皮肤科局部用抗菌剂]

[Topical antimicrobial agents in dermatology].

作者信息

Porras-Luque J I

机构信息

Dermatólogo, Centro Médico Conde de Orgaz, Madrid, España.

出版信息

Actas Dermosifiliogr. 2007 Sep;98 Suppl 1:29-39. doi: 10.1016/s0001-7310(07)70179-5.

DOI:10.1016/s0001-7310(07)70179-5
PMID:18093497
Abstract

Topical antimicrobial agents are chemical substances that, directly applied to the skin, inhibit the growth or destroy any microorganism, either fungi, viruses or bacteria. Within this term, we generally refer to those that are active against the latter. They are divided into antiseptics and antibiotics. Antiseptics are directly applied to a living organism to eradicate the existing microorganism on the mucocutaneous surfaces, preventing their proliferation. Topical antibiotics are either produced by living organisms or manufactured through synthesis and are mainly used to fight infections. Topical antimicrobials represent an important option in the prophylaxis and treatment of primary and secondary superficial bacterial infections. Antibiotics for topical use have a lower incidence of systemic toxicity, secondary effects and development of resistance than parenteral antibiotics. The ideal topical antimicrobial must have a broad spectrum of activity, fast and prolonged antibacterial effect, bactericidal activity, easy diffusion through tissues and detritus, with minimal toxicity, very low or null incidence of irritation or allergy and sparse activity against normal skin flora. The approach of this article is the description of the classical and new antimicrobials that are, more important due to their wide use and proven efficacy. We review their pharmacological characteristics, spectrum of activity, possible secondary effects and interactions, as well as the combinations that improve their antimicrobial activity, main indications and possible development of resistance, all this properly documented.

摘要

局部用抗菌剂是直接应用于皮肤的化学物质,可抑制或杀灭任何微生物,包括真菌、病毒或细菌。在此术语范围内,我们通常指那些对细菌有效的抗菌剂。它们分为防腐剂和抗生素。防腐剂直接应用于生物体,以根除粘膜皮肤表面现有的微生物,防止其增殖。局部用抗生素要么由生物体产生,要么通过合成制造,主要用于对抗感染。局部用抗菌剂是预防和治疗原发性和继发性浅表细菌感染的重要选择。与注射用抗生素相比,局部用抗生素的全身毒性、副作用和耐药性发生率较低。理想的局部用抗菌剂必须具有广谱活性、快速且持久的抗菌作用、杀菌活性、易于通过组织和碎屑扩散、毒性最小、刺激或过敏发生率极低或无、对正常皮肤菌群活性微弱。本文的方法是描述经典和新型抗菌剂,由于它们广泛使用且疗效已得到证实,因而更为重要。我们回顾它们的药理学特性、活性谱、可能的副作用和相互作用,以及提高其抗菌活性的组合、主要适应症和可能的耐药性发展,所有这些都有充分的文献记载。

相似文献

1
[Topical antimicrobial agents in dermatology].[皮肤科局部用抗菌剂]
Actas Dermosifiliogr. 2007 Sep;98 Suppl 1:29-39. doi: 10.1016/s0001-7310(07)70179-5.
2
Topical antibacterial agents for wound care: a primer.
Dermatol Surg. 2003 Jun;29(6):620-6. doi: 10.1046/j.1524-4725.2003.29143.x.
3
A review of topical therapy for skin infections with bacteria and yeast.用于治疗细菌和酵母菌皮肤感染的局部治疗综述。
Vet Dermatol. 2012 Aug;23(4):330-41, e62. doi: 10.1111/j.1365-3164.2012.01057.x. Epub 2012 Jun 25.
4
Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients.用于预防腹膜透析患者腹膜炎的抗菌药物。
Cochrane Database Syst Rev. 2017 Apr 8;4(4):CD004679. doi: 10.1002/14651858.CD004679.pub3.
5
[Topical antibiotics in skin infections].[皮肤感染中的外用抗生素]
Hautarzt. 2005 Apr;56(4):381-94; quiz 395. doi: 10.1007/s00105-005-0935-4.
6
Topical fenticonazole in dermatology and gynaecology: current role in therapy.局部用芬替康唑在皮肤科和妇科的应用:当前的治疗作用
Drugs. 2008;68(15):2183-94. doi: 10.2165/00003495-200868150-00007.
7
[Topical antiseptic agents].
Hautarzt. 2017 Oct;68(10):835-851. doi: 10.1007/s00105-017-4033-1.
8
New Topical Therapeutic Options in the Management of Superficial Fungal Infections.浅表真菌感染治疗中的新型局部治疗选择
J Drugs Dermatol. 2015 Oct;14(10 Suppl):s35-41.
9
Antimicrobial activity of topical skin pharmaceuticals - an in vitro study.局部皮肤药物的抗菌活性——一项体外研究。
Acta Derm Venereol. 2010 May;90(3):239-45. doi: 10.2340/00015555-0840.
10
[Bacterial and mycotic cutaneomucosal infections].
Rev Prat. 2006 Oct 31;56(16):1817-25.

引用本文的文献

1
Harnessing the Power of Antimicrobial Peptides: From Mechanisms to Delivery Optimization for Topical Infections.利用抗菌肽的力量:从作用机制到局部感染的递送优化
Antibiotics (Basel). 2025 Apr 4;14(4):379. doi: 10.3390/antibiotics14040379.
2
In Vitro Synergism between Azithromycin or Terbinafine and Topical Antimicrobial Agents against Pythium insidiosum.阿奇霉素或特比萘芬与外用抗菌剂对侵袭性腐霉的体外协同作用
Antimicrob Agents Chemother. 2016 Jul 22;60(8):5023-5. doi: 10.1128/AAC.00154-16. Print 2016 Aug.